Organogenesis Holdings (ORGO) Shares Outstanding (Entity) (2015 - 2026)
Organogenesis Holdings (ORGO) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.40 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.85 Bn | 30.18 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.68 Bn | 15.29 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | 834.66 Mn |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn | 128.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129.40 Mn |
| Mar 31, 2026 | 129.40 Mn |
| Dec 31, 2025 | 127.68 Mn |
| Sep 30, 2025 | 127.64 Mn |
| Jun 30, 2025 | 127.58 Mn |
| Mar 31, 2025 | 127.58 Mn |
| Dec 31, 2024 | 126.46 Mn |
| Sep 30, 2024 | 133.31 Mn |
| Jun 30, 2024 | 133.30 Mn |
| Mar 31, 2024 | 133.27 Mn |
| Dec 31, 2023 | 132.04 Mn |
| Sep 30, 2023 | 132.04 Mn |
| Jun 30, 2023 | 132.04 Mn |
| Mar 31, 2023 | 131.95 Mn |
| Dec 31, 2022 | 131.65 Mn |
| Sep 30, 2022 | 131.64 Mn |
| Jun 30, 2022 | 131.61 Mn |
| Mar 31, 2022 | 129.62 Mn |
| Dec 31, 2021 | 129.41 Mn |
| Sep 30, 2021 | 129.37 Mn |